ANB, Avalon Pharma log 2 negotiated deals worth SAR 7.8M

28/02/2024 Argaam

ANB, Avalon Pharma log 2 negotiated deals worth SAR 7.8M

Tadawul trading screen

The Saudi Exchange (Tadawul) witnessed today, Feb. 28, two negotiated deals worth SAR 7.8 million on Arab National Bank (ANB) and Middle East Pharmaceutical Industries Co. (Avalon Pharma).

 

Details

Company

Stock Price
(SAR)

Negotiated Price

(SAR)

Shares Traded
 

Deal Value
(SAR mln)

ANB

28.15

28.05

200,000

5.61

Avalon Pharma

138.40

138.40

16,039

2.22
 

For more details on negotiated deals

 

According to data available on Argaam, Avalon Pharma started trading on the main market (TASI) on Feb. 27 at SAR 82 per share.

 

A negotiated deal involves a stock purchase based on an agreement between buyers and sellers, apart from the market price. The negotiated deal is executed under the supervision of Tadawul and in adherence to the relevant capital market laws and regulations. 

 

 The negotiated deal does not directly impact the last deal price, highest/lowest stock price, opening/closing price, or market/sector indices. 

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Most Read